Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-253

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))

Label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) solution in a 10 mL multiple dose vial. The label indicates 100 mg per 10 mL strength. It is intended for infiltration and nerve block use, not for caudal or epidural use. Distributed by AuroMedics Pharma LLC and made in India. Features include storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))

Packaging label for Lidocaine Hydrochloride Injection, USP 2% (20 mg/mL), 400 mg per 20 mL multiple dose vials. The label indicates the product is for infiltration and nerve block, sterile and nonpyrogenic, containing methylparaben as a preservative. It is distributed by AuroMedics Pharma LLC and made in India. The package contains 25 vials of 20 mL each.*

FDA Label Image

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))

Lidocaine Hydrochloride 2% Injection, USP solution in a 50 mL multiple dose vial. Contains 1,000 mg per 50 mL (20 mg/mL) concentration for infiltration and nerve block use, not for caudal or epidural use. Distributed by AuroMedics Pharma LLC, made in India. Label includes storage instructions and warnings about discoloration and preservatives.*

FDA Label Image

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))

Label for Lidocaine Hydrochloride Injection, USP 2% (20 mg/mL) solution for injection, 25 multiple dose vials of 50 mL each. The label states it is for infiltration and nerve block, not for caudal or epidural use. Contains methylparaben as preservative. Distributed by AuroMedics Pharma LLC. The vial is sterile and nonpyrogenic, made in India.*

FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))

The carton label for Lidocaine Hydrochloride 1% Injection, USP, 10 mg/mL solution. The label indicates 100 mg per 10 mL, for infiltration and nerve block use, not for caudal or epidural use. The package contains 25 multiple dose vials of 10 mL each. Labeler names include Auromedics and AuroMedics Pharma LLC with distribution in E. Windsor, NJ. The label mentions methylparaben as a preservative and includes storage and usage instructions.*

FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 20 mL multiple dose vial. Provides a total of 200 mg per vial. The label indicates use for infiltration and nerve block, not for caudal or epidural use. Distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))

Packaging label for Lidocaine HCl Injection USP 1% (10 mg/mL) solution, 200 mg per 20 mL. The label indicates it is for infiltration and nerve block, not for caudal or epidural use. The package contains 25 multiple dose vials and is labeled as sterile and nonpyrogenic. Distributed by AuroMedics Pharma LLC and made in India.*

FDA Label Image

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))

Label for Lidocaine Hydrochloride Injection USP 1% (10 mg/mL) supplied as 500 mg per 50 mL solution in a multiple dose vial. The label indicates use for infiltration and nerve block and states it is not for caudal or epidural use. Distributed by AuroMedics Pharma LLC and made in India, the label includes storage instructions, barcode, and regulatory information.*

FDA Label Image

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))

Label for Lidocaine Hydrochloride Injection, USP 10 mg/mL (1%) solution, 500 mg per 50 mL vial. The label states the product is for infiltration and nerve block, not for caudal or epidural use. Contains methylparaben as preservative and is sterile, nonpyrogenic, supplied in multiple dose vials. Distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))

Label for Lidocaine HCl Injection, USP 20 mg/mL (2%) solution, 10 mL multiple dose vial. The label indicates the product is for infiltration and nerve block use, explicitly stating it is not for caudal or epidural use. The product is sterile, nonpyrogenic, contains methylparaben as a preservative, and is distributed by AuroMedics Pharma LLC, made in India.*

FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))

Carton packaging label for Lidocaine HCl Injection, USP 2% strength (20 mg/mL), 200 mg per 10 mL multiple dose vials. The label states the product is sterile, nonpyrogenic, for infiltration and nerve block use, and not for caudal or epidural use. It includes preservative methylparaben and is distributed by AuroMedics Pharma LLC. The package contains 25 vials of 10 mL each and is made in India.*

FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))

Label for Lidocaine HCl Injection USP 2% solution, containing 400 mg per 20 mL (20 mg/mL) in a 20 mL multiple dose vial. The label states it is for infiltration and nerve block, not for caudal or epidural use. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and warnings about solution appearance and preservative content.*

FDA Label Image

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

Chemical structure of Lidocaine Hydrochloride, showing the molecular arrangement including aromatic ring with methyl groups, amide linkage, diethylamino group, and hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.